Skip to main content
Livermore
Livermore
ZHEN

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

PTGX holding history

Protagonist Therapeutics, Inc in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PTGX overviewAll 13F holders of PTGXFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of PTGX by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−1,551,900−100.0%Sold outHolders
Q1 20261,551,900$163.6M0.1%+425,213+37.7%AddedHolders
Q4 20251,126,687$98.4M0.1%+888,806+373.6%AddedHolders
Q3 2025237,881$15.8M<0.1%+210,680+774.5%AddedHolders
Q2 202527,201$1.50M<0.1%−126,866−82.3%ReducedHolders
Q1 2025154,067$7.45M<0.1%−10,079−6.1%ReducedHolders
Q4 2024164,146$6.34M<0.1%+159,116+3,163.3%AddedHolders
Q3 20245,030$226.3K<0.1%+5,030NewHolders
Q2 20240$00.0%−45,616−100.0%Sold outHolders
Q1 202445,616$1.32M<0.1%−2,248−4.7%ReducedHolders
Q4 202347,864$1.10M<0.1%−2,932−5.8%ReducedHolders
Q3 202350,796$847.3K<0.1%−498,198−90.7%ReducedHolders
Q2 2023548,994$15.2M<0.1%−615,686−52.9%ReducedHolders
Q1 20231,164,680$26.8M<0.1%−1,190,634−50.6%ReducedHolders
Q4 20222,355,314$25.7M<0.1%+1,488,927+171.9%AddedHolders
Q3 2022866,387$7.30M<0.1%+792,258+1,068.8%AddedHolders
Q2 202274,129$586.0K<0.1%−112,695−60.3%ReducedHolders
Q1 2022186,824$4.42M<0.1%+151,276+425.6%AddedHolders
Q4 202135,548$1.22M<0.1%−83,156−70.1%ReducedHolders
Q3 2021118,704$2.10M<0.1%−284,504−70.6%ReducedHolders
Q2 2021403,208$18.1M<0.1%+204,990+103.4%AddedHolders
Q1 2021198,218$5.13M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.